Expression of Ki‐67, Topoisomerase IIα and c‐MYC in astrocytic tumors: Correlation with the histopathological grade and proliferative status
- 24 November 2006
- journal article
- Published by Wiley in Neuropathology
- Vol. 26 (6), 519-527
- https://doi.org/10.1111/j.1440-1789.2006.00724.x
Abstract
Astrocytomas represent the most frequent primary tumors of the central nervous system. Recently, the determination of the proliferative index of astrocytic tumors by different methods has been proposed as a valuable tool for tumor grading and also as a prognostic marker. The aim of the present study was to evaluate the expression of cell proliferation-related proteins in human astrocytic tumors of different histopathological grades (WHO). An immunohistochemical study of the Ki-67, Topoisomerase IIα (Topo IIα) and c-MYC proteins using the avidin-biotin-peroxidase method was performed in 55 astrocytomas (13 grade I, 14 grade II, 7 grade III and 21 grade IV) and five samples of non-tumor brain tissue (control group). Ki-67, Topo IIα and c-MYC positive indices tended to increase according to malignant progression, were absent in non-tumor brain tissue and showed maximum values in high-grade astrocytomas (III and IV). A gradual increase in Ki-67 antigen expression was observed in agreement with mitotic index and histopathological classification. The same was not observed for Topo IIα and c-MYC. Ki-67 antigen detection in more than 8.0% of the tumor cells distinguished astrocytoma grade IV, while a labeling index between 1.5 and 8.0% characterized astrocytomas grade III and values below 1.5% discriminated low-grade tumors (I and II). These results indicate that Topo IIα and c-MYC expression is associated with cell proliferation in astrocytomas, although not in an exclusive way. Moreover, Ki-67 antigen was found to be the best marker of cellular proliferation, and its expression predicts the grade of astrocytic tumors.Keywords
This publication has 32 references indexed in Scilit:
- A Mutation in Human Topoisomerase II α Whose Expression Is Lethal in DNA Repair-deficient Yeast CellsJournal of Biological Chemistry, 2004
- Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damageBiochemical and Biophysical Research Communications, 2004
- DNA topoisomerase IIα expression in optic pathway gliomas of childhoodEuropean Journal Of Cancer, 2002
- c-MYC: more than just a matter of life and deathNature Reviews Cancer, 2002
- Antigen Retrieval TechniquesJournal of Histochemistry & Cytochemistry, 2001
- Functional and Regulatory Characteristics of Eukaryotic Type II DNA TopoisomeraseCritical Reviews in Biochemistry and Molecular Biology, 2001
- Immunohistochemical staining of DNA topoisomerase IIα in human gliomasJournal of Neurosurgery, 1999
- Assignment of the human Ki-67 gene (MKI67)to 10q25-qterGenomics, 1991
- Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki‐67 studyNeuropathology and Applied Neurobiology, 1990
- Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissueJournal of Neurosurgery, 1989